Pharmacokinetics of methylergometrine (methylergonovine) in the rabbit and man. 1977

R Mäntylä, and T Kleimola, and J Kanto

Methylergometrine concentrations in human and rabbit plasma were determined by a new radioimmunoassay after a single intravenous injection (0.2 mg in man and 0.05, 0.1 and 0.2 mg/kg in rabbits). Both in man and in the rabbit methylergometrine disappeared quickly from the plasma with a mean T1/2alpha of 1.8 and 1.2-1.7 min. respectively. Similarly, the T1/2beta-values were 32.1 and 27.3-93.2 min. tthe mean maximal response in the rabbit uterus in situ after 0.05, 0.1 and 0.2 mg/kg intravenously dose was found at 40 sec., 26 sec., and 26 sec. after the drug administration, respectively, and the dose response curve was quite steep. A significant correlation was found between the dose and response.

UI MeSH Term Description Entries
D008755 Methylergonovine A homolog of ERGONOVINE containing one more CH2 group. (Merck Index, 11th ed) Methylergobasin,Methylergometrin,Methergin,Methergine,Methylergometrine,Methylergometrine Maleate,Methylergonovine Maleate,Méthergin
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

R Mäntylä, and T Kleimola, and J Kanto
September 1981, International journal of clinical pharmacology, therapy, and toxicology,
R Mäntylä, and T Kleimola, and J Kanto
January 1986, European journal of clinical pharmacology,
R Mäntylä, and T Kleimola, and J Kanto
June 1972, European journal of clinical pharmacology,
R Mäntylä, and T Kleimola, and J Kanto
January 1990, Drug metabolism and disposition: the biological fate of chemicals,
R Mäntylä, and T Kleimola, and J Kanto
December 2004, American journal of obstetrics and gynecology,
R Mäntylä, and T Kleimola, and J Kanto
June 1995, International journal of clinical pharmacology and therapeutics,
R Mäntylä, and T Kleimola, and J Kanto
February 1977, Research communications in chemical pathology and pharmacology,
R Mäntylä, and T Kleimola, and J Kanto
May 1985, Journal of pharmacobio-dynamics,
R Mäntylä, and T Kleimola, and J Kanto
March 1982, Journal of theoretical biology,
R Mäntylä, and T Kleimola, and J Kanto
March 1999, Xenobiotica; the fate of foreign compounds in biological systems,
Copied contents to your clipboard!